Edesa Biotech
EDSA
8 hedge funds and large institutions have $10K invested in Edesa Biotech in 2020 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
0.06% less ownership
Funds ownership: 0.07% → 0.01% (-0.06%)
11% less funds holding
Funds holding: 9 → 8 (-1)
93% less capital invested
Capital invested by funds: $145K → $10K (-$135K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Braun-Bostich & Associates
Canonsburg,
Pennsylvania
|
+$9.17K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$2.71K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$946 |
| 4 |
Wells Fargo
San Francisco,
California
|
+$41 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$103K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$41K |
EDSA Hedge Fund Activity: Q1 2020 in Review
8 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Edesa Biotech (EDSA) for Q1 2020, worth a combined $10K — down 93% from $145K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new EDSA positions and 3 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Braun-Bostich & Associates, opening a new position worth an estimated $9.17K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $103K sold.
- 8 institutional investors held Edesa Biotech (EDSA) as of Q1 2020, down from 9 in Q4 2019.
- Funds reported $10K of Edesa Biotech stock for Q1 2020, down 93% quarter-over-quarter.
- 4 funds opened new Edesa Biotech positions in Q1 2020 and 3 closed out, a net change of +1 holder.
- The largest Edesa Biotech buyer in Q1 2020 was Braun-Bostich & Associates, an estimated $9.17K added.
- The largest Edesa Biotech seller in Q1 2020 was Renaissance Technologies, an estimated $103K sold.
Based on aggregated 13F filings for Q1 2020.